Bipartisan Bill Targets Insulin Cost Cuts

A bipartisan bill promises to slash insulin prices, giving diabetes patients across America a fighting chance against skyrocketing costs driven by government meddling and pharma greed. Advocates hope this targeted reform breaks the stranglehold, putting patients over profits and bureaucrats. From a conservative view, it's proof that less regulation can deliver real relief without socialist overhauls. Millions rely on insulin - this isn't charity, it's market-driven justice for working families. Read more about this...